FOLD
AMICUS THERAPEUTICS, INC.Company with tickers: FOLD
CIK
1178879
CUSIP
03152W109
Shares Outstanding
314,000,712
13F Activity (30d)
227 filings
201 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $634,210,000 | USD | 2025-12-31 | 10-K | 2026-02-20 |
| Cost of Revenue | — | ||||
| Gross Profit | $561,281,000 | USD | 2025-12-31 | 10-K | 2026-02-20 |
| Operating Expenses | $528,492,000 | USD | 2025-12-31 | 10-K | 2026-02-20 |
| Research & Development | — | ||||
| Operating Income | $32,789,000 | USD | 2025-12-31 | 10-K | 2026-02-20 |
| Net Income | $-27,110,000 | USD | 2025-12-31 | 10-K | 2026-02-20 |
| EPS (Basic) | $-0.09 | USD/shares | 2025-12-31 | 10-K | 2026-02-20 |
| EPS (Diluted) | $-0.09 | USD/shares | 2025-12-31 | 10-K | 2026-02-20 |